Aliskiren (Rasilez) for essential hypertension: not recommended by the NHS Scotland

The Scottish Medicines Consortium issued on 5th December 2008 an advice on aliskiren (Rasilez, Tekturna in the US): Aliskiren (Rasilez) is not recommended for use within NHS Scotland for the treatment of essential hypertension. Aliskiren has shown comparable efficacy to other antihypertensive agents in terms of blood pressure reduction, though its effects on mortality and […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos